Wells Fargo & Company Morphic Holding, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$26.12 - $34.07 $156,223 - $203,772	5,981 Added 49.51%	18,062 $615,000
Q1 2024 May 10, 2024	BUY	$26.64 - $40.31 $3,143 - $4,756	118 Added 0.99%	12,081 $425,000
Q4 2023 Feb 09, 2024	SELL	$19.95 - $31.0 $425,892 - $661,788	-21,348 Reduced 64.09%	11,963 $345,000
Q3 2023 Nov 13, 2023	SELL	$21.33 - $59.42 $55,308 - $154,076	-2,593 Reduced 7.22%	33,311 $763,000
Q2 2023 Aug 15, 2023	BUY	$34.33 - $62.11 $701,018 - $1.27 Million	20,420 Added 131.88%	35,904 $2.06 Million
Q1 2023 May 12, 2023	BUY	$26.01 - $48.69 $388,095 - $726,503	14,921 Added 2650.27%	15,484 $582,000
Q4 2022 Feb 13, 2023	SELL	$24.14 - $30.37 $24,864 - $31,281	-1,030 Reduced 64.66%	563 $15,000
Q3 2022 Nov 14, 2022	SELL	$22.23 - $33.37 $4,846 - $7,274	-218 Reduced 12.04%	1,593 $45,000
Q2 2022 Aug 12, 2022	SELL	$19.74 - $43.01 $168,401 - $366,918	-8,531 Reduced 82.49%	1,811 $40,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $275,427 - $395,247	-7,598 Reduced 42.35%	10,342 $416,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $359,314 - $545,738	-8,304 Reduced 31.64%	17,940 $850,000
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $1.2 Million - $1.52 Million	-22,450 Reduced 46.1%	26,244 $1.49 Million
Q2 2021 Aug 16, 2021	BUY	$45.13 - $64.99 $17,465 - $25,151	387 Added 0.8%	48,694 $2.79 Million
Q1 2021 May 13, 2021	BUY	$29.77 - $84.85 $513,443 - $1.46 Million	17,247 Added 55.53%	48,307 $3.06 Million
Q4 2020 Feb 09, 2021	BUY	$25.66 - $34.55 $129,634 - $174,546	5,052 Added 19.42%	31,060 $1.04 Million
Q3 2020 Nov 05, 2020	SELL	$22.51 - $30.11 $84,232 - $112,671	-3,742 Reduced 12.58%	26,008 $711,000
Q2 2020 Aug 13, 2020	BUY	$12.65 - $29.57 $272,809 - $637,706	21,566 Added 263.51%	29,750 $805,000
Q1 2020 May 14, 2020	BUY	$10.84 - $20.85 $88,714 - $170,636	8,184 New	8,184 $120,000

Others Institutions Holding MORF

# of Institutions

Shares Held

4.7M

Call Options Held

Put Options Held

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account